CLINICAL_TRIALS
trial_result
· 2020-11-25
Clinical Trial Update: Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches [Phase 2]
Summary
Phase 2 trial updating abatacept effects in systemic lupus erythematosus using integrated biologic and clinical approaches; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oklahoma Medical Research Foundation | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2020-11-25